EDGAR 10-K Filing

Company CIK: 1438901
Filing Year: 2022
Filename: 1438901_10-K_2022_0001161697-22-000222.json

---

ITEM 1. BUSINESS
Item 1. Business.
Company
Auto Parts 4Less Group, Inc. formerly The 4LESS Group, Inc., also previously known as MedCareers Group, Inc. (the “Company”, “MCGI”), was incorporated under the laws of the State of Nevada on December 5, 2007. The Company formally operated a website for nurses, nursing schools and nurses’ organizations designed for better communication between nurses and the nursing profession.
On November 29, 2018, the Company entered into a transaction (the “Share Exchange”), pursuant to which the Company acquired 100% of the issued and outstanding equity securities of The 4LESS Corp. (“4LESS”), in exchange for the issuance of (i) nineteen thousand (19,000) shares of Series B Preferred Stock, (ii) six thousand seven hundred fifty (6,750) shares of Series C Preferred Stock, and (iii) 870 shares of Series D Preferred Stock. The Series C Preferred Shares have a right to convert, and was converted in December 2021 into common stock of the Company by multiplying the number of issued and outstanding shares of common stock by 2.63 on the conversion date. The Share Exchange closed on November 29, 2018. As a result of the Share Exchange, the former shareholders of 4LESS became the controlling shareholders of the Company. The Share Exchange was accounted for as a reverse takeover/recapitalization effected by a share exchange, wherein 4LESS is considered the acquirer for accounting and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the shares issued as a result of the reverse merger except otherwise noted.
4Less was formed as Vegas Suspension & Offroad, LLC on October 24, 2013 as a Nevada limited liability company and converted to a Nevada corporation with the same name on May 8, 2017. On April 2, 2018, the Company changed its name to The 4Less Corp. The Corporation had S Corporation status. The Corporation operated as an e-commerce auto and truck parts sales company. As a result of the share exchange, the Company became a holding company operating through 4Less and offers products including exhaust systems, suspension systems, wheels, tires, stereo systems, truck bed covers, and shocks.
Auto Parts 4Less Group, Inc. formerly The 4LESS Group, Inc. (“4Less”, the “Company”, “we” or “us”), the Company described herein, is a Nevada corporation, with offices located at 106 W Mayflower, Las Vegas, NV 89030. It can be reached by phone at (702) 267-6100.
- 3 -
History
The Company was formed as RX Scripted, LLC on December 30, 2004 as a North Carolina limited liability company and converted to a Nevada corporation as RX Scripted, Inc. on December 5, 2007.
On or around January 7, 2010 the Company’s name was changed to MedCareers Group, Inc. Additionally, as a result of filing the Certificate, the Company’s symbol on the Over-The-Counter Bulletin Board changed to “MCGI”, effective January 7, 2010.
On or around November 19, 2010, the Company entered into a Share Exchange Agreement (the “Exchange”) with Nurses Lounge, Inc., a Texas corporation (“Nurses Lounge”) and the nine shareholders of Nurses Lounge (the “Nurses Lounge Shareholders”). Pursuant to the Exchange, we agreed to issue 24,000,000 restricted shares of our common stock to the Nurses Lounge Shareholders in exchange for 100% of the issued and outstanding shares of common stock of Nurses Lounge. Although 24,000,000 restricted shares were issued in connection with the Exchange, certain significant shareholders of the Company also agreed to cancel some of the shares they owned so that the net effect of the Exchange was an increase to the outstanding shares by 7,175,000 shares rather than 24,000,000. Included in the shareholders receiving shares in connection with the Exchange, was Timothy Armes founder and president of Nurses Lounge, Inc., who received 14,902,795 shares. In December 2019 Nurses Lounge was disposed of as more fully described elsewhere in this Form 10-K and in the Notes to the Financial Statements.
Auto Parts 4Less
Like many small businesses, Christopher Davenport, the founder of Auto Parts 4Less (“4Less”) previously named The 4less Corp., the wholly owned subsidiary of Auto Parts 4Less Group, Inc., began selling auto parts on eBay and shipping those items out of his garage in 2013. What started out as a hobby, quickly grew into a fully functioning ecommerce aftermarket auto parts company that required a significant technical staff and facilities to support their growth. In June of 2015, they leased their first office.
Originally the company listed their auto parts in the different marketplaces such as Amazon, eBay, Walmart and Jet. Starting in 2016 the company began investing to become their own ecommerce platform thereby allowing their auto parts to be direct listed across marketplace and social media sites. Technical achievements including CRM system, warehouse integration API, warehouse inventory software to name a few.
In 2019, shortly after the share exchange with MedCareers Group, Inc., with technology upgrades in place, 4Less began successfully moving majority of sales from third party marketplaces direct to their proprietary ecommerce web site Liftkits4Less.com. By doing so the company saves 8%-10% in fees charged by the major marketplace’s such as e-Bay and Amazon as well as further building the 4less brand as a leading ecommerce site for auto parts.
On November 19, 2019 the Company acquired the URL Autoparts4Less.com and changed the name of their wholly owned subsidiary from the 4Less Corp. to Auto Parts 4Less, Inc. With the acquisition of the URL AutoParts4Less.com, the Company also began focusing all of their efforts and resources on building out a flagship automotive marketplace with the potential to offer buyers a wide range of automotive parts for cars, trucks, boats, motorcycles and RV’s on a single platform.
In August 2021 the Company launched a beta test version of Autoparts4less.com. In a short period of time after the beta launch the company realized that with the amount of interest received from numerous types of larges sellers, which included not only ecommerce sites presently selling parts online, but also interest from other large parts sellers such as warehouse distributors, new car dealers with large inventories of parts as well as brick and mortar parts retailers looking to move sales online, the platform originally created would soon be inadequate. As such, the Company made the decision to upgrade to a larger and more advanced platform solution so they immediately began implementation of the AWS Fargate serverless platform solution.
The platform upgrade will be done in late 1st quarter FYE 2023, with marketplace sales expected to begin in 2nd quarter 2023.
On April 28. 2022 the Company changed its name from The 4LESS Group, Inc. to Auto Parts 4Less Group, Inc.
Competition
We directly compete for buyers to use our web sites over current e-commerce sites as well as sellers that utilize major marketplaces such as Amazon and eBay. However, we believe our specialty ecommerce website liftkits4less.com offers substantial value-added content including installation guides, install videos, high impact photos, order customization and live chat with a technical expert.
Additionally, we believe that our automotive parts marketplace AutoParts4less.com, with no known large challengers presently in the space outside of “all things to all people” online marketplaces Amazon and eBay, has the opportunity to quickly be branded when launched as the auto part’s industry premier marketplace just as sites like Etsy, Wayfair, Uber and Chewey’s have been able to successfully do in their industries.
- 4 -

---

ITEM 1A. RISK FACTORS
Item 1A. Risk Factors
Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), we are not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

---

ITEM 1B. UNRESOLVED STAFF COMMENTS
Item 1B. Unresolved Staff Comments
Not applicable.

---

ITEM 2. PROPERTIES
Item 2. Properties.
Executive Offices
We maintain offices at 106 W Mayflower, Las Vegas, Nevada 89030. We pay monthly rent of $6,400 and our lease expires on June 30, 2022, with an additional one year renewal.

---

ITEM 3. LEGAL PROCEEDINGS
Item 3. Legal Proceedings.
None.

---

ITEM 4. MINE SAFETY DISCLOSURE
Item 4. Mine Safety Disclosures.
None.
PART II

---

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
The Company’s common stock is traded on the OTC Pink market (otherwise known as the “pink sheets”) maintained by OTC Markets under the symbol “FLES”. The following table sets forth, for the periods indicated, the high and low sales prices, which set forth reflect inter-dealer prices, without retail mark-up or mark-down and without commissions; and may not reflect actual transactions. The Company effected a 10:1 reverse split on April 26,2022 , so the post reverse split prices are shown.
Calendar Quarter Ending Low High
$ $
January 31, 2022 6.80 20.00
October 31, 2021 9.50 23.90
July 31, 2021 17.00 22.50
April 30, 2021 20.60 34.50
January 31, 2021 2.00 44.80
October 31, 2020 0.60 64.00
July 31, 2020 0.50 2.00
April 30, 2020 1.10 4.00
No cash dividends on the Company common stock have been declared or paid since the Company’s inception. The Company had approximately 119 shareholders at April 26, 2022. This does not include shareholders that hold their shares in street name or with a broker.
- 5 -
Recent Sales of Unregistered Securities
Preferred Stock
On June 11, 2018, we filed with the state of Nevada designations for Series C and D Preferred Stock of the Company, as well as amended designation for our Series A and B Preferred Stock. Series A Preferred Stock consists of 330,000 authorized shares. Series A Preferred shares have no voting rights and carry conversion rights into common stock of the Company at a rate equal to factor of total issued and outstanding common stock a the time of conversion divided by 0.0152. Series B Preferred Stock consists of 20,000 shares. Series B shares in total shall have voting rights equal 66.7% of the total voting rights (all common shares plus all other series of preferred stock as if they had converted on that date). Series C Preferred Stock consists of 7,250 shares. The total of the Series C Preferred shares shall convert to our common stock by multiplying the number of issued and outstanding shares of common stock by 2.63 on the conversion date. Conversion is automatic as of December 31, 2022, regardless of the acts of the holders. Series D Preferred Stock consists of 870 shares. Series D Preferred shares have no voting rights and are redeemable for $1,000 per share at the discretion of either the holder us. For more details regarding the right and obligations of the respective series of preferred stock, please review the Exhibits 3.1-3.4. filed on Edgar on November 13, 2018 and incorporated herein by reference.
During the year the ended January 31, 2022, there were no transactions of Preferred stock.
On February 1, 2022 all Series C shareholders holding all 7,250 outstanding shares converted all of their shares for 905,111common shares.
- 6 -
Common Stock
Consideration
Date
# Shares
Number of shares outstanding,
January 31, 2017
2.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $6,050 of principal and $2,341 of accrued interest
15-Nov-17
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $4,400 of principal and $1,743 of accrued interest
29-Nov-17
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $4,400 of principal and $1,745 of accrued interest
8-Dec-17
0.3
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,550 of principal
19-Jan-18
0.1
Accrued expenses converted to common stock - related party
Convert a portion of accrued expense of $2,250
31-Jan-18
0.1
Accrued expenses converted to common stock - related party
Convert a portion of accrued expense of $1,125
31-Jan-18
0.1
Accrued expenses converted to common stock
Convert a portion of accrued expense of $750
31-Jan-18
-
Common stock issued for services
Services valued at $3,000
31-Jan-18
-
Common stock issued for services
Services valued at $300
31-Jan-18
-
Number of shares outstanding,
January 31, 2018
3.5
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $2,200 of principal and $1,145 of accrued interest
6-Jun-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1,760 of principal and $978 of accrued interest
30-Jul-18
0.2
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1,650 of principal and $944 of accrued interest
9-Oct-18
0.2
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1,540 of principal and $941 of accrued interest
22-Oct-18
0.2
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $6,373 of accrued interest
9-Nov-18
0.1
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $2,750 of accrued interest
9-Nov-18
0.2
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,950 of accrued interest
15-Nov-18
0.2
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $13,863 of principal and $9,176 of accrued interest
16-Nov-18
0.1
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,235 of accrued interest
19-Nov-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,108 of principal and $1,890 of accrued interest
21-Nov-18
0.4
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1,322 of principal and $2,328 of accrued interest
23-Nov-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1,540 of principal and $941 of accrued interest
30-Nov-18
0.4
Cancelation of shares
Cancellation in conjunction with acquisition
30-Nov-18
(0.3)
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,717 of principal and $133 of accrued interest
30-Nov-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,958 of principal and $92 of accrued interest
3-Dec-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $4,216 of principal and $84 of accrued interest
6-Dec-18
0.4
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,190 of principal and $1,981 of accrued interest
10-Dec-18
0.4
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,843 of principal and $127of accrued interest
11-Dec-18
0.3
- 7 -
Common Stock (continued)
Consideration
Date
# Shares
Cancellation in conjunction with disposal of subsidiary
Shares cancelled due to spinoff of subsidiary and discontinued operations
12-Dec-18
(0.2)
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $4,885 of principal and $114 of accrued interest
16-Nov-18
0.4
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $4,950 of principal and $3,096 of accrued interest
16-Nov-18
0.7
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $5,191 of principal and $58 of accrued interest
16-Nov-18
0.4
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $5,934 of principal and $16 of accrued interest
16-Nov-18
0.5
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,088 of principal and $61 of accrued interest
16-Nov-18
0.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $5,500 of principal and $3,480 of accrued interest
16-Nov-18
0.7
Convert a portion of accrued expense
Convert a portion of accrued expense of $1,125
31-Dec-18
0.1
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $6,732 of principal and $158 of accrued interest
10-Jan-19
0.6
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $5,500 of principal and $3,523 of accrued interest
10-Jan-19
0.8
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $7,547 of principal and $48 of accrued interest
17-Jan-19
0.6
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $8,000 of accrued interest
18-Jan-19
0.7
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $9,240 of principal and $6,034 of accrued interest
18-Jan-19
1.3
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $2,535 of accrued interest
22-Jan-19
0.3
Number of shares outstanding,
January 31, 2019
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,952 of principal and 4,844 of accrued interest
1-Feb-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,202 of principal and $42 of accrued interest
15-Feb-19
-
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,527 of principal and $5,473 of accrued interest
25-Feb-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $10,494 of principal and $56 of accrued interest
26-Feb-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $10,945 of principal and $7,428 of accrued interest
26-Feb-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $11,072 of principal and $45 of accrued interest
27-Feb-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,534 of principal and $66 of accrued interest
1-Mar-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $13,172 of principal and $78 of accrued interest
5-Mar-19
1.
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,100 of principal and $8,179 of accrued interest
5-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $9,265 of interest and $500 of fees
5-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $3,887 of principal, $6,602 of interest and $500 of fees
6-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $8,611 of principal, $59 of interest and $500 of fees
7-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $11,321 of principal, $219 of interest and $500 of fees
11-Mar-19
- 8 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $17,600 of principal and $11,966 of accrued interest
11-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $12,121 of principal, $49 of interest and $500 of fees
12-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $8,592 of principal, $43 of interest and $500 of fees
13-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $9,401 of principal, $39 of interest and $500 of fees
14-Mar-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $8,743 of principal, $207 of interest and $500 of fees
20-Mar-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,100 of principal and $8,357of accrued interest
5-Apr-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $1 of principal and $378 of accrued interest
5-Apr-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $8,800 of principal and $6,223 of accrued interest
30-Apr-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $432 of accrued interest
30-Apr-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $469 of accrued interest
2-May-19
Common stock at issued 52% discount to market per note conversion agreement
Convert a portion of note payable including $8,416 of principal, $196 of interest and $500 of fees
2-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $22,000 of principal and $6,738 of accrued interest
7-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $13,300 of principal, $202 of interest and $500 of fees
10-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $11,051 of principal, $27 of interest and $500 of fees
14-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,139 of principal
16-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,613 of principal and $1,892 of accrued interest
16-May-19
-
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,600 of principal and $4,428 of accrued interest
16-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,196 of principal
17-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,317 of principal
20-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $854 of principal
21-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,317 of principal
22-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $739 of principal
23-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,538 of principal
28-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,538 of principal
28-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,593 of principal
30-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,799 of principal
31-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $11,000 of principal and $8,320 of accrued interest
31-May-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,879 of principal
3-Jun-19
- 9 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $15,362 of principal and $11,670 of accrued interest
5-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,599 of interest
5-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,798 of principal and $1,518 of accrued interest
11-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including 3,300 of principal and $2,443 of accrued interest
11-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $11,364 of principal and $62 of accrued interest
13-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $12,016 of principal and $24 of accrued interest
14-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $11,625 of principal and $47 of accrued interest
17-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,780 of principal and $8 of accrued interest
18-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,405 of principal and $671 of accrued interest
19-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,165 of accrued interest
20-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,985 of principal and $7,679 of accrued interest
21-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $10,022 of principal and $114 of accrued interest
24-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,064 of principal and $32 of accrued interest
25-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,872 of principal and $56 of accrued interest
27-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,376 of principal and $24 of accrued interest
28-Jun-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,215 of principal and $59 of accrued interest
1-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $8,057 of principal and $17 of accrued interest
2-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,154 of principal and $12 of accrued interest
3-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,807 of principal and $43 of accrued interest
8-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,122 of principal
8-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,922 of principal and $8 of accrued interest
10-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,244 of accrued interest
11-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,081 of accrued interest
12-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,347 of principal and $4,133 of accrued interest
15-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,147 of principal and $38 of accrued interest
16-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,872 of principal and $106 of accrued interest
19-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,095 of principal and $96 of accrued interest
22-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,293 of principal and $29 of accrued interest
23-Jul-19
- 10 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,467 of principal and $25 of accrued interest
24-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,722 of principal and $21 of accrued interest
25-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,022 of principal and $18 of accrued interest
26-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,389 of principal and $41 of accrued interest
29-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,731 of principal and $10 of accrued interest
30-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,855 of principal and $8 of accrued interest
31-Jul-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,056 of principal and $5 of accrued interest
1-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,033 of principal and $3 of accrued interest
3-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,759 of accrued interest
5-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,721 of accrued interest
6-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,997 of accrued interest
7-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $229 of principal and $3,529 of accrued interest
8-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,123 of principal and $157 of accrued interest
12-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,552 of principal and $36 of accrued interest
13-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,864 of principal and $32 of accrued interest
14-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,132 of principal and $28 of accrued interest
15-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,802 of principal and $98 of accrued interest
19-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,674 of principal and $22 of accrued interest
20-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,089 of principal and $20 of accrued interest
21-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,127 of principal and $17 of accrued interest
22-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,534 of principal and $13 of accrued interest
23-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,846 of principal and $27 of accrued interest
26-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,030 of principal and $209 of accrued interest
27-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,603 of accrued interest
28-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,987 of accrued interest
29-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,503 of principal and $1,518 of accrued interest
30-Aug-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,662 of principal and $141 of accrued interest
3-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,997 of principal and $64 of accrued interest
5-Sep-19
- 11 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,064 of principal and $115 of accrued interest
9-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,851 of principal and $25 of accrued interest
10-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,549 of principal and $23 of accrued interest
11-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,927 of principal and $21 of accrued interest
12-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,802 of principal and $18 of accrued interest
13-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,055 of principal and $49 of accrued interest
16-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,531 of principal and $13 of accrued interest
17-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,645 of principal and $18 of accrued interest
19-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,647 of principal and $7 of accrued interest
20-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,171 of principal and $13 of accrued interest
23-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,347 of principal and $2 of accrued interest
24-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $248 of principal and $1,546 of accrued interest
25-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,633 of accrued interest
26-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,853 of accrued interest
27-Sep-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,599 of accrued interest
1-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,777 of principal and $656 of accrued interest
2-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,843 of principal and $19 of accrued interest
3-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,543 of principal and $17 of accrued interest
4-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,090 of principal and $45 of accrued interest
7-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,287 of principal and $13 of accrued interest
8-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,460 of principal and $11 of accrued interest
9-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,639 of principal and $9 of accrued interest
10-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,829 of principal and $6 of accrued interest
11-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,186 of accrued interest
14-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,160 of accrued interest
15-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,212 of principal and $18 of accrued interest
16-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,318 of principal and $1,079 of accrued interest
17-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,562 of accrued interest
18-Oct-19
- 12 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,717 of principal and $1,676 of accrued interest
21-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,374 of principal and $19 of accrued interest
22-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,158 of principal and $16 of accrued interest
23-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,319 of principal and $14 of accrued interest
24-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,486 of principal and $12 of accrued interest
25-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,989 of principal and $29 of accrued interest
28-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,167 of principal and $8 of accrued interest
29-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,331 of principal and $6 of accrued interest
30-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,506 of principal and $4 of accrued interest
31-Oct-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,952 of principal and $919 of accrued interest
2-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,003 of accrued interest
4-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,265 of accrued interest
5-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,383 of accrued interest
6-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $977 of principal and $1,528 of accrued interest
14-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,084 of principal and $76 of accrued interest
18-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,886 of principal and $35 of accrued interest
20-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $392 of principal and $1,000 of fees
20-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,999 of principal and $16 of accrued interest
21-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,409 of principal and $15 of accrued interest
22-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,476 of interest and $750 of fees
25-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,591 of interest and $750 of fees
26-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $840 of principal and $1,000 of fees
26-Nov-19
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $2,082 of principal and $750 of fees
27-Nov-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,765 of principal and $2,177 of accrued interest
27-Nov-19
1,177
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,812 of interest and $750 of fees
29-Nov-19
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $2,646 of principal and $750 of fees
2-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,213 of interest and $750 of fees
2-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,148 of interest and $750 of fees
3-Dec-19
- 13 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $2,958 of principal and $750 of fees
3-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,567 of principal and $2,144 of accrued interest
4-Dec-19
1,452
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,820 of interest and $750 of fees
4-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $920 of interest and $1,000 of fees
4-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $670 of principal, $2,990 of interest and $750 of fees
5-Dec-19
1,050
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,859 of principal, $53 of interest and $750 of fees
6-Dec-19
1,110
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,690 of principal and $750 of fees
6-Dec-19
1,075
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $112 of principal and $1,000 of fees
9-Dec-19
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,002 of principal, $151 of interest and $750 of fees
9-Dec-19
1,167
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $3,298 of principal and $750 of fees
10-Dec-19
1,265
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $3,591 of principal, $48 of interest and $750 of fees
10-Dec-19
1,045
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,190 of principal, $45 of interest and $750 of fees
10-Dec-19
1,425
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $7,282 of principal and $2,401 of accrued interest
12-Dec-19
2,423
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $4,282 of principal and $750 of fees
12-Dec-19
1,572
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,176 of principal, $84 of interest and $750 of fees
13-Dec-19
1,075
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,028 of principal, $122 of interest and $750 of fees
16-Dec-19
1,750
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,392 of principal, $38 of interest and $750 of fees
17-Dec-19
1,850
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,938 of principal, $35 of interest and $750 of fees
18-Dec-19
1,945
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $4,386 of principal and $1,472 of accrued interest
18-Dec-19
1,464
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,052 of principal, $169 of interest and $750 of fees
23-Dec-19
2,122
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $6,380 of principal and $714 of accrued interest
23-Dec-19
3,547
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $2,530 of principal and $750 of fees
23-Dec-19
2,050
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,844 of principal, $519 of interest and $750 of fees
8-Jan-20
2,252
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,500 of principal, $250 of interest and $750 of fees
16-Jan-20
2,500
Common shares issuable upon rounding of shares on reverse split
31-Jan 20
Number of shares outstanding,
January 31, 2020
53,846
- 14 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $316 of principal
30-Mar-20
2,630
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,585 of principal and $498 of accrued interest
24-Apr-20
5,606
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,793 of principal and $374 of accrued interest
18-May-20
6,104
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $412 of principal.
10-Jun-20
3,320
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,782 of principal and $405 of accrued interest
17-Jun-20
7,045
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,035 of principal and $474 of accrued interest
25-Jun-20
7,720
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $380 of principal.
6-Jul-20
4,225
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $2,001 of accrued interest
28-Aug-20
8,894
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $557 of accrued interest
3-Sep-20
2,485
Common stock at issued 55% discount to market per note conversion agreement
Convert a portion of note payable including $358 of interest and $750 of fees
10-Sep-20
4,950
Common stock issued
Repayment of accrued expenses for $18,900
21-Sep-20
4,500
Common stock at issued 50% discount to market per note conversion agreement
Payment of commitment fee on loan for $50,000
13-Oct-20
1,969
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $1,091 of accrued interest
3-Nov-20
4,870
Common stock issued
Payment of commitment fee on loan for $20,001
17-Nov-20
Common stock issued
Payment of commitment fee on loan for $43,750
24-Nov-20
1,750
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $5,000 of principal and $4,397 of accrued interest
31-Dec-20
1,506
Common stock at issued 50% discount to market per note conversion agreement
Convert a portion of note payable including $10,500 of principal and $9,027 of accrued interest
31-Dec-20
3,129
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $50,000
15-Jan-21
2,500
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $50,000
15-Jan-21
2,500
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
15-Jan-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
15-Jan-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $50,000
31-Jan-21
2,500
Number of shares outstanding,
January 31, 2021
142,716
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
17-Feb-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $150,000
18-Feb-21
7,500
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
19-Feb-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $200,000
19-Feb-21
10,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $120,000
2-Mar-21
6,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $200,000
2-Mar-21
10,000
- 15 -
Common Stock (continued)
Consideration
Date
# Shares
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $282,500
10-Mar-21
14,125
Common stock issued for consulting fees
Fair value of $107,500
15-Mar-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $25,000
18-Mar-21
1,250
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
1-Apr-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $50,000
4-Apr-21
2,500
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
14-Apr-21
5,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $200,000
20-Apr-21
10,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $7,500
20-Apr-21
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $99,500
20-Apr-21
4,975
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $200,000
22-Apr-21
10,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
23-Apr-21
5,000
Common stock issued pursuant to REG A subscription
$$2.00 per share for gross proceeds of $50,000
28-Apr-21
2,500
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $110,000
28-Apr-21
5,500
Common stock issued at previous day bid price per note conversion agreement
Convert a portion of note payable including $18,750 of principal, and $1,750 of fees
27-May-21
1,000
Common stock issued at previous day bid price per note conversion agreement
Convert a portion of note payable including $36,850 of principal, and $1,750 of fees
21-Jun-21
2,000
Common stock issued with debt
Relative fair value of $31,006
8-Jul-21
3,096
Common stock issued with debt
Relative fair value of $28,975
21-Jul-21
6,085
Common stock issued
Fair value of $191,000
22-Jul-21
10,000
Common stock issued at previous day bid price per note conversion agreement
Convert a portion of note payable including $25,000 of principal, $13,250 of interest, and $1,750 of fees
9-Aug-21
2,000
Common stock issued with debt
Value included with 8-Jul-21 transaction above
11-Aug-21
1,548
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $75,000
12-Aug-21
3,750
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $5,000
13-Aug-21
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $47,000
16-Aug-21
2,350
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $100,000
17-Aug-21
5,000
Common stock issued to broker as fees
Fair value of $30,055.
19-Aug-21
1,301
Common stock issued pursuant to share purchase agreement
$1.53 per share for gross proceeds of $306,000
24-Aug -21
20,000
Common stock issued pursuant to REG A subscription
$2.00 per share for gross proceeds of $4,500
7-Sep-21
Common stock issued pursuant to share purchase agreement
$1.16 per share for gross proceeds of $139,320
8-Sep-21
12,000
Common stock issued at previous day bid price per note conversion agreement
Convert a portion of note payable including $25,000 of principal, $13,250 of interest, and $1,750 of fees
9-Sep-21
2,000
Common stock issued at previous day bid price per note conversion agreement
Convert a portion of note payable including $25,000 of principal, $13,250 of interest, and $1,750 of fees
10-Sep-21
1,977
Common stock issued pursuant to share purchase agreement
$0.95 per share for gross proceeds of $85,050
7-Oct-21
9,000
Number of shares outstanding,
January 31, 2022
341,023
- 16 -
Summary of Common Stock Shares Issued in the Year ended January 31, 2022
During the year ended January 31, 2022, the Company issued 172,300 shares for cash proceeds of $3,037,625. A lender converted $125,000 of the convertible notes, $27,691 of accrued interest and $7,500 of fees into 8,977 common shares. The Company issued 6,301 shares with a fair value of $137,555 as payment for fees to consultants. The Company issued 10,729 shares to lenders as commitment fee with a relative fair value of $59,801.
Summary of Common Stock Shares Issued in the Year ended January 31, 2021
During the year ended January 31, 2021, a lender converted a total of $24,803 of the convertible notes and $19,933 accrued interest and $20,185 of derivative liability into 62,485 common shares. We also issued: 17,500 shares for cash proceeds of $350,000 as part of a REG A subscription, 4,385 shares for $35,060 as commitment fees for loans, and 4,500 shares for $18,900 as payment on accrued expenses, related party.
Summary of Class C Preferred Stock Issued in the year ended January 31, 2022:
No transactions.
Summary of Class C Preferred Stock Issued in the year ended January 31, 2021:
● 250 shares valued at $9,105 in exchange of debt
● 100 shares to repay Accrued Expenses , Related Party for $11,177
● 150 shares as part of a debt settlement for $20,290
Options and Warrants
We had the following options and warrants outstanding at January 31, 2022:
Issued To # Warrants and Options Dated Expire Strike Price Expired Exercised
Lender 95,000 08/28/2020 08/28/2023 $4.00 per share N N
Broker 10/11/2020 10/11/2025 $45.00 per share N N
Broker 11/25/2020 11/25/2025 $30.00 per share N N
Triton 30,000 07/27/2021 07/27/2024 $21.11 per share N N
Consultant 25,000 08/26/2021 08/26/2024 $15.00 per share N N
T. Armes 50,000 10/14/2021 10/14/2023 $15.00 per share N N
Lender 90,000 11/12/2021 11/12/2026 $15.00 per share N N
Lender 90,000 11/12/2021 11/12/2026 $15.00 per share N N
Lender 30,000 01/27/2022 01/27/2025 $15.00 per share N N
All of the above transactions our exempt from registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Act”) since the foregoing issuances and grants did not involve a public offering, the recipients took the shares and options for investment and not resale, the Company took appropriate measures to restrict transfer, and the recipients were either (a) “accredited investors” and/or (b) had access to similar documentation and information as would be required in a Registration Statement under the Act. No underwriters or agents were involved in the foregoing issuances and the Company paid no underwriting discounts or commissions.
EQUITY COMPENSATION PLAN INFORMATION
The Company has no shareholder approved compensation plans.

---

ITEM 6. SELECTED FINANCIAL DATA
Item 6. Selected Financial Data.
Not applicable.
- 17 -

---

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Results of Operations For the Year Ended January 31, 2022 compared to the year ended January 31, 2021
The following table shows our results of operations for the years ended January 31, 2022 and 2021, The historical results presented below are not necessarily indicative of the results that may be expected for any future period.
Change
$
%
Total Revenues
$ 11,018,751
$ 8,171,355
$ 2,847,396
35%
Gross Profit
1,547,447
1,460,628
86,819
6%
Total Operating Expenses
9,005,439
3,602,462
5,402,977
150%
Total Other Income (Expense)
(611,764 )
3,329,010
(3,940,774 ) (118% )
Net Income (Loss)
$ (8,069,756 ) $ 1,187,176
$ (9,256,932 ) (780% )
Revenue
The following table shows revenue split between proprietary and third party website revenue for the years ended January 31, 2022 and 2021:
Change
$
%
Proprietary website revenue
$ 7,576,068
$ 4,200,624
$ 3,375,444
80%
Third party website revenue
3,442,683
3,970,731
(528,048 ) (13% )
Total Revenue
$ 11,018,751
$ 8,171,355
$ 2,847,396
35%
We had total revenue of $11,018,757 for the year ended January 31, 2022, compared to $8,171,355 for the year ended January 31, 2021. Sales increased by $2,847,396 or 35%. This large increase can be attributed to many factors such as; economic stimulus payments from government, large increase in product offering, aggressive advertising and promotion, and economic growth emerging from pandemic. The Company at January 31, 2022 had $665,143 (2021-$687,786) of deferred revenue which represents orders received before January 31, 2022 but delivered after. This will be revenue that the Company recognizes in the first quarter ended April 30, 2022. Also, the Company had $530,900 (2021-$188,385) in customer deposits which represents orders received before January 31, 2022 but either cancelled or still unfulfilled after. Both deferred revenues and deposits were a result of inventory shortages and supplier back-order issues. The Company believes that of the unrecognized revenue (deferred revenue and customer deposits combined) in 2022 which totals $1,196,043, $927,518 was a result of supply chain issues with the remaining $268,525 caused by normal operating issues. We do continue to grow our proprietary website revenues which increased by 80% offset by a reduction in third party website revenue by 13%.
Gross Profit
We had gross profit of $1,547,447 for the year ended January 31, 2022, compared to gross profit of $1,460,628 for the year ended January 31, 2021. Gross profit increased by $86,819, yet gross profit % decreased to 14% in fiscal 2022 from 18% in fiscal 2021.
Gross profit increased because of the 35% increase in sales however this was reduced because cost of revenue was higher because the Company had to purchase goods at higher product costs from distributers rather than the usual manufacturers for many of the new available products or some of the products that were not available from the usual manufacturers due to supply chain issues.
- 18 -
Operating Expenses
The following table shows our operating expenses for the years ended January 31, 2022 and 2021. Operating expenses increased to $9,005,439 for the year ended January 31, 2022 from $3,602,462 for the year ended January 31, 2021:
Change
$
%
Operating expenses
Depreciation
$ 48,931
$ 25,196
$ 23,735
94%
Postage, Shipping and Freight
531,954
498,370
33,584
7%
Marketing and Advertising
2,430,905
112,531
2,318,374
2,060%
E Commerce Services, Commissions and Fees
1,569,825
887,274
682,551
77%
Operating lease cost
121,917
121,917
-
0%
Personnel Costs
1,482,448
1,128,652
353,796
31%
PPP Loan Forgiveness
(209,447 )
-
(209,447 ) -
General and Administrative
3,028,906
828,522
2,200,384
266%
Total Operating Expenses
$ 9,005,439
$ 3,602,462
$ 5,402,977
150%
• Depreciation increased by $23,735 due to asset additions totaling $196,569 in 2022, thus a higher asset value is being depreciated.
• Postage shipping and freight increased by $33,584 due to higher sales.
• Marketing and advertising increased by $2,318,374 due to strong promotional efforts geared to increasing brand awareness of the website as well as targeted advertising.
• E Commerce Services, Commissions and Fees increased by $682,551 with approximately $47,000 due to increased sales and approximately $636,000 on the new website.
• Personnel Costs decreased by $353,796 due to some isolated salary increases as well as staff increases in fiscal 2022 compared to fiscal 2021 which saw staff reductions as a result of the pandemic.
• General and Administrative increased by $2,200,384. This increase is attributed to a non cash charge of $ 1,677,055 to stock based compensation, $425,090 increase in professional fees (which comprise of accounting, legal, reporting and transfer agent costs), and $188,215 increase in investor relations.
Other Income (Expense)
The following table shows our other income and expenses for the years ended January 31, 2022 and 2021:
Change
$
%
Other Income (Expense)
Gain (Loss) on Sale of Property and Equipment
$ 20,345
$
$ 19,881
4,285%
Gain (Loss) on Derivatives
235,703
(828,614 )
(1,064,317 ) 128%
Gain on Settlement of Debt
1,410,113
5,060,704
(3,650,591 ) (72% )
Amortization of Debt Discount
(918,463 )
(335,004 )
(583,459 ) 174%
Interest Expense
(1,359,462 )
(568,540 )
(790,922 ) 139%
Total Other Income (Expense)
$ (611,764 ) $ 3,329,010
$ (3,940,774 ) (118% )
The results of the year ended January 31, 2022 resulted in other expense of $611,764 vs other income of $3,329,010 for the year ended January 31, 2021. For the year ended January 31, 2022 the Company acquired more short term debt which resulted in higher interest costs and debt amortization. For the year ended January 31, 2021 there were debt settlements and exchanges which resulted in the increase in gain on settlement of debt and lower interest expense. Fair value of derivatives was largely affected by the increase in the market price of our common stock during the current period as well as the significant reduction in convertible debt.
We had net loss of $8,069,756 for the year ended January 31, 2022, compared to net income of $1,187,176 for the year ended January 31, 2021 due mainly to the gain on debt settlement for the year ended January 31, 2021 , the higher interest and debt amortization, share based compensation and marketing and advertising for the year ended January 31, 2022 and the other factors mentioned above.
- 19 -
Liquidity and Capital Resources
As of January 31, 2022, we had cash and cash equivalents of $77,498 of cash, $432,583 of inventory and total current liabilities of $8,890,462. We had negative working capital of $8,325,847 as of January 31, 2022.
Net cash used in operations for the year ended January 31, 2022 was $6,340,468 compared to $859,821 for the year ended January 31, 2021.The use of cash in operations was caused by the net loss offset by non -cash adjustments.
Net cash (used in) provided from investing activities for the year ended January 31, 2022 was ($18,568) compared to $9,750 for the year ended January 31, 2021.
Cash provided by financing activities for the year ended January 31, 2022 was $6,158,870 compared to $965,611 for the year ended January 31, 2021. In both years the cash provided from financing activities was from the proceeds from the issuance of common shares and the net proceeds of notes payable and short term debt and in 2021 the PPP loan.
Subsequent to year end, through the date of filing of this Form 10-K, the company issued loans totaling $2,100,000 for cash proceeds of $1,728,250.
We borrowed funds and/or sold stock for working capital. These transactions are detailed in the section “Recent Sales of Unregistered Securities”.
Currently, we don’t have sufficient cash reserves to meet its contractual obligations and its ongoing monthly expenses, which we anticipate totaling approximately $6,000,000 over the next 12 months. Historically, revenues have not been sufficient to cover operating costs that would permit us to continue as a going concern. These conditions raise substantial doubt about our ability to continue as a going concern. We have been able to continue operating to date largely from loans made by its shareholders, other debt financings and sale of common stock. We are currently looking at both short-term and more permanent financing opportunities, including debt or equity funding, bridge or short-term loans, and/or traditional bank funding, but we have not decided on any specific path moving forward. Until we have raised sufficient funding to pay our ongoing expenses associated with being a public company, and we have sufficient funds to support our planned operations, we can provide no assurances that it will be able to meet its short and long-term liquidity needs, until necessary financing is secured.
We do not currently have any additional formal commitments or identified sources of additional capital from third parties or from our officers, director or significant shareholders. We can provide no assurance that additional financing will be available on favorable terms, if at all. If we are not able to raise the capital necessary to continue our business operations, we may be forced to abandon or curtail our business plan.
In the future, we may be required to seek additional capital by selling additional debt or equity securities, selling assets, if any, or otherwise be required to bring cash flows in balance when we approach a condition of cash insufficiency. The sale of additional equity or debt securities, if accomplished, may result in dilution to our then shareholders. We provide no assurance that financing will be available in amounts or on terms acceptable to us, or at all.
Critical Accounting Policies
Revenue Recognition
The Company recognizes revenue under ASC 606, “Revenue from Contracts with Customers. The core principle of the revenue standard is that a company should recognize revenue when control is transferred over the promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the goods and services transferred to the customer. The following five steps are applied to achieve that core principle:
Step 1: Identify the contract with the customer
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance obligations in the contract
Step 5: Recognize revenue when the company satisfies a performance obligation
Because the Company’s sales agreements generally have an expected duration of one year or less, the Company has elected the practical expedient in ASC 606-10-50-14(a) to not disclose information about its remaining performance obligations.
- 20 -
Disaggregation of Revenue: Channel Revenue
The following table shows revenue split between proprietary and third party website revenue for the years ended January 31, 2022 and 2021:
Change
$
%
Proprietary website revenue
$ 7,576,068
$ 4,200,624
$ 3,375,444
80%
Third party website revenue
3,442,683
3,970,731
(528,048 ) (13% )
Total Revenue
$ 11,018,751
$ 8,171,355
$ 2,847,396
35%
The Company’s performance obligations are satisfied at the point in time when products are received by the customer, which is when the customer has title and obtained the significant risks and rewards of ownership. Therefore, the Company’s contracts have a single performance obligation (shipment of product). The Company primarily receives fixed consideration for sales of product. Shipping and handling amounts paid by customers are primarily for online orders and are included in revenue. Sales tax and other similar taxes are excluded from revenue.
Revenue is recorded net of provisions for discounts and promotion allowances, which are typically agreed to upfront with the customer and do not represent variable consideration. Discounts and promotional allowances vary the consideration the Company is entitled to in exchange for the sale of products to customers. The Company recognizes these discounts and promotional allowances in the same period that the revenue is recognized for products sales to customers. The amount of revenue recognized represents the amount that will not be subject to a significant future reversal of revenue. The customer pays the Company by credit card prior to delivery.
The Company offers a 30 day satisfaction guaranteed return policy however the customer must pay for the return shipment. The return must be previously authorized, cannot be either damaged or previously installed and must be in saleable condition. In the Company’s experience this amount is immaterial and therefore no provision has been recorded on the Company’s books. Any defective merchandise falls under the manufacturer’s limited warranty and is subject to the manufacturer’s inspection. The manufacturer has the option to repair or replace the item.
All sales to customers are generally final. However, the Company accepts returned product due to quality or issues relating to product description or incorrect product orders and in such instances the Company would replace the product or refund the customers funds The Company’s customers generally pre-pay for the products.
Use of Estimates
In order to prepare financial statements in conformity with accounting principles generally accepted in the United States, management must make estimates, judgments and assumptions that affect the amounts reported in the financial statements and determine whether contingent assets and liabilities, if any, are disclosed in the financial statements. The ultimate resolution of issues requiring these estimates and assumptions could differ significantly from resolution currently anticipated by management and on which the financial statements are based. The most significant estimates included in these consolidated financial statements are those associated with the assumptions used to estimate deferred revenue and customer deposits and value derivative liabilities.
Fair Value of Financial Instruments
The Company’s financial instruments consist of cash, accounts payable, advances and notes payable. The Company considers the carrying value of such amounts in the financial statements to approximate their fair value due to the short-term nature of these financial instruments. Derivatives are recorded at fair value at each period end. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date.
The ASC guidance for fair value measurements and disclosure establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are described below:
- 21 -
Level 1 Inputs - Quoted prices for identical instruments in active markets.
Level 2 Inputs - Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable.
Level 3 Inputs - Instruments with primarily unobservable value drivers.
As of January 31, 2022 and 2021, the Company’s derivative liabilities were measured at fair value using Level 3 inputs. See Note 9.
The following table sets forth, by level within the fair value hierarchy, the Company’s financial liabilities that were accounted for at fair value on a recurring basis as of January 31, 2022:
January 31, 2022
Quoted Prices in
Active Markets
For Identical
Assets
(Level 1)
Significant
Other
Observable
Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Liabilities:
Derivative Liabilities - embedded redemption feature
$ 1,263,442
$ -
$ -
$ 1,263,442
Totals
$ 1,263,442
$ -
$ -
$ 1,263,442
Derivative Liability
The derivative liabilities are valued as a level 3 input under the fair value hierarchy for valuing financial instruments. The derivatives arise from convertible debt where the debt and accrued interest is convertible into common stock at variable conversion prices. As the price of the common stock varies, it triggers a gain or loss based upon the discount to market assuming the debt was converted at the balance sheet date. When evaluating the effect of the issuance of new equity-linked or equity-settled instruments on previously issued instruments, the Company uses first-in, first-out method (“FIFO”) where authorized and unused shares would first be used to satisfy the earliest issued equity-linked instruments. As of January 31, 2022, the Company had warrants to purchase 360,550 common shares and stock options to purchase 50,000 common shares.
The fair value of the derivative liability is determined using a lattice model, is re-measured on the Company’s reporting dates, and is affected by changes in inputs to that model including our stock price, historical stock price volatility, the expected term, and both high risk and the risk-free interest rate. The most sensitive inputs to the model are for expected time for the holder to convert or be repaid and the estimated historical volatility of the Company’s common stock. However, because the historical volatility of the Company’s common stock is so high, the sensitivity required to change the liability by 1% as of January 31, 2022 is greater than 25% change in historical volatility as of that date. The other inputs, such as risk free rate, high yield cash rate and stock price all have a sensitivity for a 1% change in the input variable results in a significantly less than 1% change in the calculated derivative liability.

---

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Item 7A. Quantitative and Qualitative Disclosures about Market Risk.
Pursuant to Item 305(e) of Regulation S-K (§ 229.305(e)), we are not required to provide the information required by this Item as it is a “smaller reporting company,” as defined by Rule 229.10(f)(1).

---

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Item 8. Financial Statements and Supplementary Data.
The Company’s consolidated financial statements, together with the report of the independent registered public accounting firm thereon and the notes thereto, are presented beginning at page. The Company’s balance sheets as of January 31, 2022 and 2021 and the related statements of operations, changes in stockholders’ deficit and cash flows for the years then ended have been audited by independent registered public accounting firm L J Soldinger Associates, LLC.. These financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and pursuant to Regulation S-K as promulgated by the Securities and Exchange Commission and are included herein pursuant to Part II, Item 8 of this Form 10-K. The financial statements have been prepared assuming the Company will continue as a going concern.
- 22 -
Table of Contents of Financial Statements
Page
Report of Independent Registered Public Accounting Firm
Financial Statements:
Consolidated Balance Sheets as of January 31, 2022 and 2021
Consolidated Statements of Operations for the Years Ended January 31, 2022 and 2021
Consolidated Statement of Changes in Stockholders’ Deficit for the Years Ended January 31, 2022 and 2021
Consolidated Statements of Cash Flows for the Years Ended January 31, 2022 and 2021
Notes to the Consolidated Financial Statements for the Years Ended January 31, 2022 and 2021

---

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
Item 9. Change in and Disagreements with Accountants on Accounting and Financial Disclosure.
None

---

ITEM 9A. CONTROLS AND PROCEDURES
Item 9A. Controls and Procedures.
Evaluation of Disclosure on Controls and Procedures
We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of January 31, 2022. This evaluation was accomplished under the supervision and with the participation of our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) who concluded that our disclosure controls and procedures were not effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), as appropriate, to allow timely decisions regarding required disclosure.
We have identified the following material weaknesses and significant deficiencies:
Material weaknesses
• The failure of the Company to adequately invest the resources necessary to properly account for and report upon its financial position and results of operations under the requirements of US GAAP.
• The Company incorrectly records revenue in its accounting systems at the time of the customer’s order. Under ASC 606 “Revenue From Contracts With Customers”, revenue is recognized when the Company’s performance obligation is satisfied at the point in time when the product is received by the customer.
In order to remedy our existing internal control deficiencies, as our finances allow, we will hire additional accounting staff.
Management’s Annual Report on Internal Control Over Financial Reporting
Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our internal control system was designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes, in accordance with generally accepted accounting principles in the United States of America. Our internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of inherent limitations, a system of internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate due to change in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
- 23 -
Our management conducted an evaluation of the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013 Internal Control-Integrated Framework) at January 31, 2021. Based on its evaluation, our management concluded that, as of January 31, 2022, our internal control over financial reporting was not effective because of limited staff and a need for a full time chief financial officer and the identification of the material weaknesses described above. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis.
This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to the attestation by the Company’s registered public accounting firm pursuant to rules of the SEC that permit the Company to provide only management’s report in this annual report.
Changes in Internal Controls over Financial Reporting
There were no changes in our internal control over financial reporting during our most recent fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

---

ITEM 9B. OTHER INFORMATION
Item 9B. Other Information.
None.
PART III

---

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Item 10. Directors, Executive Officers and Corporate Governance.
The following table lists the names and ages of the executive officers and director of the Company. The director(s) will continue to serve until the next annual shareholders meeting, or until their successors are elected and qualified. All officers serve at the discretion of the Board of Directors.
Name
Age
Position
Date First Appointed/ Elected To the Company
Timothy Armes
Chairman, Chief Executive Officer, President,
Secretary and Treasurer and President and Chief
Executive Officer of Auto Parts 4Less Group, Inc.
August 2011
Chris Davenport
President of Autoparts4less
October 2013
Timothy Armes: Mr. Armes has served as President and Chief Executive Officer of Auto Parts 4Less Group, Inc (formerly The 4Less Group, Inc. and MedCareers Group, Inc.) since August 2011. From February 2011 to August 2011, Mr. Armes served as the Chief Operating Officer of the Company. Since August 2011, Mr. Armes has served as the Chairman, Chief Executive Officer, President, Secretary and Treasurer of the Company. In 1992 Mr. Armes launched one of the first online job bulletin boards which eventually grew into jobs.com. As CEO of Jobs.com he raised over 100 million dollars and grew it into one of the top employment web sites before leaving the company in May of 2000. Mr. Armes began his career as an auditor for Ernst and Young and then as a real estate workout specialist with different firms in the mid 1980’s. Mr. Armes obtained a Bachelor of Business Administration degree in Accounting from the University of Texas in 1980 and passed the Certified Public Accountant exam.
Director Qualifications:
We believe that Mr. Armes is well qualified to serve as a Director of the Company because of his significant experience working with and building Nurses Lounge (which since November 2010 has been our wholly-owned operating subsidiary); his prior experience growing Jobs.com, and his financial and accounting background.
Christopher Davenport: Mr. Davenport received his MBA from the University of California in September 2005 where he was recognized by his classmates as “the Most Innovative Thinker”. Before founding The 4Less Corp, Mr. Davenports’ previous business provided mobile dental services to the employees of the largest gaming corporations in the world. These contracts covered the lives of several hundred thousand employees on the Las Vegas strip. Due to the nature of the mobile facilities, Mr. Davenport implemented several new technologies at the time such as: filmless radiography, virtual patient charts and VPN networks to make for seamless quality health care. Soon after, Mr. Davenport expanded his mobile dental company to the military where he won several multiyear, multi-million dollars medical/dental National Guard Medical Readiness contracts. Mr. Davenport has a proven history of implementing innovative technologies that demonstrates his ability to lead The 4Less Corp into the future.
- 24 -
Corporate Governance
We promote accountability for adherence to honest and ethical conduct; endeavors to provide full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the Securities and Exchange Commission (the “SEC”) and in other public communications made by the Company; and strives to be compliant with applicable governmental laws, rules and regulations.
In lieu of an Audit Committee, our Board of Directors (currently consisting solely of Timothy Armes), is responsible for reviewing and making recommendations concerning the selection of outside auditors, reviewing the scope, results and effectiveness of the annual audit of our financial statements and other services provided by our independent public accountants. The Board of Directors reviews our internal accounting controls, practices and policies.
Committees of the Board
We do not currently does not have nominating, compensation, or audit committees or committees performing similar functions nor do we have a written nominating, compensation or audit committee charter. The Board of Directors believes that it is not necessary to have such committees, at this time, because the functions of such committees can be adequately performed by the sole director.
Audit Committee Financial Expert
Our Board of Directors has determined that we do not have an independent board member that qualifies as an “audit committee financial expert” as defined in Item 407(D)(5) of Regulation S-K, nor do we have a Board member that qualifies as “independent” as the term is used in Item 7(d)(3)(iv)(B) of Schedule 14A under the Exchange Act.
We believe that our sole director is capable of analyzing and evaluating our financial statements and understanding internal controls and procedures for financial reporting. The sole director does not believe that it is necessary to have an audit committee because management believes that the functions of an audit committee can be adequately performed by the sole director. In addition, we believe that retaining an independent director who would qualify as an “audit committee financial expert” would be overly costly and burdensome and is not warranted in our circumstances given the stage of our development and the fact that we have not generated any positive cash flows from operations to date.
Involvement in Certain Legal Proceedings
Our sole director and our executive officer has not been involved in any of the following events during the past ten years:
1. any bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;
2. any conviction in a criminal proceeding or being subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
3. being subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining, barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; or
4. being found by a court of competent jurisdiction (in a civil action), the Commission or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated.
Board Meetings and Annual Meeting
During the fiscal year ended January 31, 2022, our Board of Directors (currently consisting solely of Timothy Armes) did not meet or hold any formal meetings. We did not hold an annual meeting in the year ended January 31, 2022. In the absence of formal board meetings, the Board conducted all of its business and approved all corporate actions during the fiscal year ended January 31, 2022 by the unanimous written consent of its sole director.
- 25 -
Code of Ethics
We have not adopted a formal Code of Ethics. The Board of Directors evaluated the business of the Company and the number of employees and determined that since the business is operated by a small number of persons, general rules of fiduciary duty and federal and state criminal, business conduct and securities laws are adequate ethical guidelines. In the event our operations, employees and/or directors expand in the future, we may take actions to adopt a formal Code of Ethics.
Shareholder Proposals
We do have any defined policy or procedural requirements for shareholders to submit recommendations or nominations for directors. The sole director believes that, given the stage of our development, a specific nominating policy would be premature and of little assistance until our business operations develop to a more advanced level. We do not currently have any specific or minimum criteria for the election of nominees to the Board of Directors and we do not have any specific process or procedure for evaluating such nominees. The Board of Directors will assess all candidates, whether submitted by management or shareholders, and make recommendations for election or appointment.
A shareholder who wishes to communicate with our Board of Directors may do so by directing a written request addressed to our Chief Executive Officer, at the address appearing on the first page of this report.

---

ITEM 11. EXECUTIVE COMPENSATION
Item 11. Executive Compensation.
Summary Compensation Table
The table below summarizes the total compensation paid or earned by our Chief Executive Officer and Chief Financial Officer during the fiscal years ended January 31, 2022 and 2021. We did not have any executive officers who received total compensation in excess of $100,000 during the fiscal years disclosed below, other than disclosed below.
Name and principal position (1)
Year
Salary*
Bonus
Stock Awards
Option Awards
All other compensation*
Total compensation
Timothy Armes
$ 150,000
-
-
$585,000
-
$ 735,000
CEO, President, Treasurer, Secretary and Director (1)
$ 91,701
-
-
-
-
$ 91,701
Christopher Davenport
$ 612,790
-
-
-
-
$ 612,790
President Autoparts4Less
$ 550,200
-
-
-
-
$ 550,200
__________
* Does not include any accruals not paid in cash or perquisites and other personal benefits in amounts less than 10% of the total annual salary and other compensation. No executive officer earned any non-equity incentive plan compensation or nonqualified deferred compensation during the periods reported above. The value of the Stock Awards and Option Awards in the table above, if any, was calculated based on the fair value of such securities calculated in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718.
(1) No executive or director received any consideration, separate from the compensation they received as an executive officer, for service on the Board of Directors of the Company during the periods disclosed.
Grants of Plan-Based Awards. None.
Outstanding Equity Awards at Fiscal Year End. Stock option to purchase 50,000 held by CEO.
Potential Payments upon Termination or Change in Control
We do not have any contract, agreement, plan or arrangement with its named executive officers that provides for payments to a named executive officer at, following, or in connection with the resignation, retirement or other termination of a named executive officer, or a change in our control, or a change in the named executive officer’s responsibilities following a change in control.
Retirement Plans
We do not have any plan that provides for the payment of retirement benefits, or benefits that will be paid primarily following retirement.
- 26 -
Compensation of Directors
In the past, we have not instituted a policy of compensating non-management directors. However, we plans to use stock-based compensation to attract and retain qualified candidates to serve on its Board of Directors. In setting director compensation, we will consider the significant amount of time that directors expend in fulfilling their duties to us, as well as the skill-level that we require.

---

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
The following table sets forth information regarding the beneficial ownership of our voting common stock, as of April 25, 2022, by: (i) each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock; (ii) each of our officers and directors (provided that Mr. Armes currently serves as our sole director); and (iii) all of our officers and directors as a group.
Based on information available to us, all persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them, unless otherwise indicated. Beneficial ownership is determined in accordance with Rule 13d-3 under the Securities Exchange Act of 1934, as amended. In computing the number of shares beneficially owned by a person or a group and the percentage ownership of that person or group, shares of our common stock subject to options or warrants currently exercisable or exercisable within 60 days after the date of this filing are deemed outstanding, but are not deemed outstanding for the purpose of computing the percentage of ownership of any other person. The following table is based on 1,447,476 common shares issued and outstanding as of April 25, 2022 reflecting the reverse splits.
COMMON STOCK
Beneficial Owner
Address
Shares
Percent Ownership
Common Stock Timothy Armes
Chairman / CEO
President, Secretary, CFO
106 W Mayflower,
Las Vegas, Nevada 89030
16,985
1.17%
Common Stock Chris Davenport
Founder and President Autoparts4Less
106 W Mayflower,
Las Vegas, Nevada 89030
758,420
52.40%
All Officers and Directors as a Group
(2 Persons)
775,405
53.57%
Greater than 5% Shareholders
Chris Davenport
758,420
52.40%
Sergio Salzano
84,269
5.82%
All 5% Shareholders as a Group
842,689
58.22%
The following table is based on 0 shares of Series A Preferred Shares outstanding, 20,000 of Series B Preferred Shares outstanding, 0 shares of Series C Preferred Shares outstanding and 870 shares of Series D Preferred shares outstanding as of April 25, 2022.
- 27 -
PREFERRED STOCK
Beneficial Owner
Address
Class
Shares
Percent Ownership
Preferred Stock Timothy Armes
Chairman / CEO
President, Secretary, CFO
106 W Mayflower,
Las Vegas, Nevada 89030
Pref A
Pref B
Pref C
Pref D
1,000
0.00%
5.00%
0.00%
13.79%
Preferred Stock Chris Davenport
Founder and President of Autoparrts4Less
106 W Mayflower,
Las Vegas, Nevada 89030
Pref A
Pref B
Pref C
Pref D
17,100
0.00%
90.00%
0.00%
77.58%
All Officers and Directors as a Group
(2 Persons)
Pref A
Pref B
Pref C
Pref D
18,100
0.00%
90.50%
0.00%
91.38%
Greater than 5% Shareholders
Pref A
Pref B
Pref C
Pref D
1,900
0.00%
9.50%
0.00%
8.62%

---

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
Item 13. Certain Relationships and Related Transactions, and Director Independence.
As a result of the acquisition of the 4Less Corp in November 2018 and disposition of Nurses Lounge in December of 2018, Mr. Armes canceled 100 million shares (1,666 post split) of his approximate 129,628,000 common shares he owned (2,160 post split). Along with the cancellation of his common stock and a verbal agreement to stay on as our President, CEO and Chairman of the Board. Mr. Armes received 120 shares of Series D Preferred stock, maintained his 1,000 shares of Series B Preferred stock, received 100 Class C preferred shares (during the year ended January 31, 2021) and a payable to Mr. Armes representing $180,000 of deferred income of which a balance of $ 46,173 remains payable at January 31, 2022. On February 1, 2022 Mr Armes converted his 100 Class C preferred shares for 12,484 common shares.
As part of the acquisition of The 4Less Corp., Christopher Davenport, the founder and president of The 4Less Corp, received 17,100 shares of Series B Preferred Stock representing approximately 89% of the 20,000 Series B Preferred stock outstanding, 6,075 shares of Series C Preferred stock outstanding which can be converted into approximately 60% of our outstanding common stock and 675 shares of Series D Preferred stock. On February 1, 2022 Mr. Davenport Armes converted his 6075 Class C preferred shares for 758,420 common shares.
Review, Approval and Ratification of Related Party Transactions
Given our small size and limited financial resources, we had not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described above, with our executive officers, director(s) and significant stockholders. However, we make it a practice of having our Board of Directors (currently consisting solely of Mr. Armes) approve and ratify all related party transactions. In connection with such approval and ratification, our Board of Directors takes into account several factors, including their fiduciary duties to us; the relationships of the related parties to us; the material facts underlying each transaction; the anticipated benefits to us and related costs associated with such benefits; whether comparable products or services are available; and the terms we could receive from an unrelated third party.
We intend to establish formal policies and procedures in the future, once we have sufficient resources and have appointed additional directors, so that such transactions will be subject to the review, approval or ratification of our Board of Directors, or an appropriate committee thereof. On a moving forward basis, the Board of Directors will continue to approve any related party transaction based on the criteria set forth above.
Director Independence
We currently only have one director, Timothy Armes, who is not independent. We have plans to appoint three independent directors in 3rd quarter of FYE 2023.
- 28 -

---

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Item 14. Principal Accounting Fees and Services.
(1) Audit Fees
The aggregate fees billed for professional services rendered by our auditors, for the audit of the registrant’s annual financial statements and review of the financial statements included in the registrant’s Form 10-K and Form 10-Q(s) for services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements, for fiscal year 2022 was approximately $346,057, for audit and 10-Q fees.
(2) Audit Related Fees
None.
(3) Tax Fees
$10,850
(4) All Other Fees
The aggregate fees billed for professional services rendered by our auditors for work related to registration statements during fiscal year 2022 was $56,580 and the aggregate fees billed for work related to the PPP credit was $3,730.
PART IV

---

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
Item 15. Exhibits and Financial Statement Schedules.
1. Consolidated Financial Statements
Page
Report of Independent Registered Public Accounting Firm
Financial Statements:
Consolidated Balance Sheets as of January 31, 2022 and 2021
Consolidated Statements of Operations for the Years Ended January 31, 2022 and 2021
Consolidated Statement of Changes in Stockholders’ Deficit for the Years Ended January 31, 2022 and 2021
Consolidated Statements of Cash Flows for the Years Ended January 31, 2022 and 2021
Notes to the Consolidated Financial Statements for the Years Ended January 31, 2022 and 2021
2. Financial Statement Schedules
Schedules have been omitted because they are not required, not applicable, or the required information is otherwise included.
3. Exhibits
See the Exhibit Index immediately following the signature page of this Annual Report on Form 10-K.
- 29 -